CIK: 1383292 - Address: C/O Orchard Therapeutics Plc, 245 Hammersmith Road, London, X0 W6 8PW
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret112-5-25-3-20-1
S%wins10050010010070

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/18/23 18:31
5/16/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRowland Charles A JrCADS.d-1,00025.000-40-5730D
8/3/22 21:48
8/1/22
NBRVNabriva Therapeutics PlcL2HealthDrugPharmaceutical PreparationsRowland Charles A JrPADS-10.17500-8-3615D
8/4/21 21:05
8/2/21
NBRVNabriva Therapeutics PlcL2HealthDrugPharmaceutical PreparationsRowland Charles A JrPADS-11.200-1-324D
12/18/20 16:09
12/17/20
BPMCBlueprint Medicines CorpDEHealthDrugPharmaceutical PreparationsRowland Charles A JrMADS.d-1,285117.820-11-754D
11/4/20 17:18
11/2/20
BPMCBlueprint Medicines CorpDEHealthDrugPharmaceutical PreparationsRowland Charles A JrMADS.dm-98998.900-10-744D
6/24/19 20:08
6/20/19
BPMCBlueprint Medicines CorpDEHealthDrugPharmaceutical PreparationsRowland Charles A JrMADS.d-1,12495.150-12-1000D
3/5/12 16:01
3/1/12
VPHMViropharma IncDEHealthDrugPharmaceutical PreparationsRowland Charles A JrPAOVP,CFOS.d-2,65832.1233-83-8317D1537965369761-6-9
3/15/11 16:50
3/14/11
VPHMViropharma IncDEHealthDrugPharmaceutical PreparationsRowland Charles A JrPAOVP,CFOS.d-65018.5719-35-5528D3064037101382-3-355-3-2

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact